Skip to content
OpenCapital
Get started

Aurinia Pharmaceuticals AUPH EV / sales

EV / sales at other companies

Rogers Corporation logo
Rogers CorporationROG
2.1×+0.8×
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
1.9×-0.5×
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
2.7×-4.0×
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
28.8×-15.8×
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
4.6×+1.6×
Alumis Inc. logo
Alumis Inc.ALMS
330.2×—

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.3B+78.5%
Enterprise value$2.34B+78.3%
P/E7.7×-24.6×
P/S7.7×+2.5×

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Calculated from Aurinia Pharmaceuticals’s reported figures.

enterprise value/total revenue=6.8×

Based on the most recent quarter.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's EV / sales?
Aurinia Pharmaceuticals (AUPH) reported EV / sales of 6.8× in Q1 2026.
How has Aurinia Pharmaceuticals's EV / sales changed year-over-year?
Aurinia Pharmaceuticals's EV / sales increased by 47.8% year-over-year, from 4.6× to 6.8×.
What is the long-term trend for Aurinia Pharmaceuticals's EV / sales?
Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's EV / sales has grown at a -26.2% compound annual growth rate (CAGR), from 34.2× to 7.5×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.